Plné znění - 80/2017 Sb. m. s.

Sdělení o přijetí nového znění Přílohy I (Seznam zakázaných látek a metod dopingu pro rok 2017 - Mezinárodní standard) Mezinárodní úmluvy proti dopingu ve sportu

80/2017 Sb. m. s.

Sdělení

INFORMACE

80

SDĚLENÍ

Ministerstva zahraničních xxxx,

xxxxxx xx xxxx x xxxxxxxx sdělení Xxxxxxxxxxxx xxxxxxxxxxxx xxxx č. 58/2007 Sb. m. x. x x. 46/2008 Xx. x. x.

 

Xxxxxxxxxxxx xxxxxxxxxxxx věcí xxxxxxx, že xxx 28. listopadu 2016 xxxx xxxxxxxxx ředitelkou XXXXXX oznámeno xxxxxxxxx xxxxxx znění Xxxxxxx X (Seznam xxxxxxxxxx xxxxx x xxxxx xxxxxxx xxx rok 2017 - Xxxxxxxxxxx xxxxxxxx) Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾.

X xxxxx xxxxxx Xxxxxxx X vyslovil xxxxxxx Parlament České xxxxxxxxx a prezident xxxxxxxxx xxxxxxxx listinu x xxxxxxx změn Xxxxxxx X Xxxxxx xxxxxxxxxx.

Xxxx xxxxx Xxxxxxx X vstoupilo x xxxxxxxx x souladu x článkem 34 xxxx. 3 Xxxxxx dne 1. ledna 2017 x xxx Xxxxxx xxxxxxxxx vstoupilo v xxxxxxxx dne 30. xxxxx 2017.

Dnem xxxxxx xxxxxx znění Xxxxxxx X x xxxxxxxx xxxxxxxx platit xxxxx Xxxxxxx I platné xx 1. xxxxx 2016, vyhlášené xxx č. 26/2017 Sb. m. s.

Xxxxxxxx xxxxx Xxxxxxx X x její xxxxxxx xx xxxxxxx xxxxxx se xxxxxxxxx xxxxxxxx.

XXXXXXX XXXXXXXXXXXXX XXXXX

XXXXXX XXXXXXXXXX XXXXX X XXXXX XXXXXXX XXX XXX 2017

XXXXXXXXXXX XXXXXXXX

Xxxxxxxxx xxxx Seznamu xxxx xxxxxxxxx WADA x xxxx xxxxxxxxxx v xxxxxxxxxx a francouzštině.

V xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxx anglickou a xxxxxxxxxxxx xxxxx xxxx xxxxxxxxxxx anglická verze.

Tento Xxxxxx bude xxxxxx xx 1. xxxxx 2017 

XXXXXX XXXXXXXXXX LÁTEK X XXXXX DOPINGU XXX XXX 2017

SVĚTOVÝ XXXXXXXXXXXXX KODEX

Platný od 1. xxxxx 2017

Podle xxxxxx 4.2.2 Světového xxxxxxxxxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx xxxxx xxxxxxxxxx za "Specifické xxxxx" xxxxx xxxxx xx skupin S1, X2, X4.4, X4.5 x X6(x) a Xxxxxxxxxx xxxxx X1, X2 x M3.

LÁTKY X METODY ZAKÁZANÉ XXXXX (XXX XXXXXXX X XXXX SOUTĚŽ)

ZAKÁZANÉ XXXXX

X0. XXXXXXXXXXX XXXXX

Xxxxxxxxx farmakologicky xxxxxx látka, xxxxx xxxx xxxxxxxx x xxxxxxxxxxxxx sekcích Xxxxxxx x xxxx xxxxxxxx xxxxxxxxx xxx humánní xxxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxxxx zdravotnickým xxxxxxxxxx xxxxxx (xxxx. xxxxxx x xxxxxxxxxxxx xxxx xxxxxxxxx xxxxxx výzkumu xxxx xx xxxxxxxx xxxxxxxxxx, syntetické drogy, xxxxx xxxxxxxxx pouze xxx veterinární použití), xx xxxxxxxx stále.

S1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx xxxx zakázány.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (AAS):

(a) Xxxxxxxx* AAS, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3ß,17ß-xxxx);

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx);

xxxxxxxxx (estr-4-en-3ß, 17ß-xxxx);

xxxxxxxxxx;

xxxxxxx ([1,2]xxxxxxx[4',5':2,3]xxxxxx-4-xx-20-xx-17α-xx);

xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx);

xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxxx-5α-xxxxxxx-2-xx-17ß-xx);

xxxxxxxxxxx;

xxxxxxxxxxxxx (19-xxxxxxxxx-4-xx-17α-xx);

xxxxxxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxx (17α-xxxxxx[1,2,5]xxxxxxxxxx[3',4':2,3]-5α-xxxxxxxxx-17ß-xx);

xxxxxxxxx;

4-xxxxxxxxxxxxxxxxxx (4,17ß-xxxxxxxxxxxxxxxx-4-xx-3-xx);

xxxxxxxxxx;

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxx (17ß-hydroxy-17α-methylandrosta-1,4-dien-3-on);

metenolon;

methandriol;

metasteron (17ß-xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xx);

xxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xx);

xxxxxx-1-xxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxx-5α-xxxxxxx-1-xx-3-xx);

xxxxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xx);

xxxxxXxxxxxxxxxxx;

xxxxxxxxxx (xxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9,11-xxxxx-3-xx);

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxxxxx;

xxxxxxxxxxxx;

xxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxx (17ß-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxxx);

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxx;

1-xxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxx-1-xx-3-xx);

xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18α-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx);

xxxxxxxxx (17ß-xxxxxxxxxxx-4,9,11-xxxxx-3-xx);

x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Endogenní** XXX, xxxxx xxxx xxxxxx xxxxxxxx:

Xxxxxxxxxxxxx (androst-5-en-3ß,17ß-diol);

androstendion (xxxxxxx-4-xx-3,17-xxxx);

xxxxxxxx;

xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx);

xxxxxxxxxxxxxxxxxx (17ß-hydroxy-5α-androstan-3on); 

nandrolon (19-xxxxxxxxxxxxxx);

19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);

19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);

xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX, 3ß-xxxxxxxxxxxxxx-5-xx-17-xx);

xxxxxxxxxxx;

x jejich xxxxxxxxxx a isomery, xxx xx s xxxxxxxx pouze xx xx:

5α-xxxxxxxxx-3α,17α-xxxx;

5α-xxxxxxxxx-3α,17ß-xxxx;

5α-xxxxxxxxx-3ß,17α-xxxx;

5α-xxxxxxxxx-3ß,17ß-xxxx;

5ß-xxxxxxxxx-3α,17ß-xxxx;

5α-xxxxxxx-2-xx-17-xx;

xxxxxxx-4-xx-3α,17α-xxxx;

xxxxxxx-4-xx-3α,17ß-xxxx;

xxxxxxx-4-xx-3ß,17α-xxxx;

xxxxxxx-5-xx-3α,17α-xxxx;

xxxxxxx-5-xx-3α,17ß-xxxx;

xxxxxxx-5-xx-3ß,17α-xxxx;

4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3ß,17ß-xxxx);

5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx);

xxxxxxxxxxx;

xxx-xxxxxxxxxxxxxxxxxx;

xxxxxxxxxxxxxx;

xxxxxxxxxxxxxx;

3ß-xxxxxxx-5α-xxxxxxxxx-17-xx;

7α-xxxxxxx-XXXX;

7ß-xxxxxxx-XXXX;

7-xxxx-XXXX;

19-xxxxxxxxxxxxxx;

19-xxxxxxxxxxxxxxxxx.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx; selektivní xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX, xxxx. andarin x xxxxxxx); xxxxxxx; xxxxxxx x xxxxxxxxxx, ale xx x omezením xxxxx xx xx.

Xxx xxxxx xxxxxxx této xxxxx: * "xxxxxxxx" xx xxxxxxxx x látce, xxxxxx xxxx xxxxxxxx xxxxxxxxx neprodukuje. ** "xxxxxxxxx " se vztahuje x xxxxx, xxxxxx xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx.

X2. XXXXXXXXX HORMONY, XXXXXXX XXXXXXX, PŘÍBUZNÉ XXXXX A XXXXXXXX

Xxxxxxxxxxx xxxxx x xxxxx xxxxx s podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx xxxx xxxxxxxx:

1. Xxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxx:

1.1 Xxxxx xxxxxxxxxxx xxxxxxxxxxx (XXX) xxxxxx xxxx.

xxxxxxxxxxxx (xXXX);

xxxxxxxxxxxxx (XXX);

XXX-Xx;

XXX-xxxxxxxxxxx peptidů (XXX), xxxx. CNTO 530 x xxxxxxxxxxx;

xxxxxxxxxx XXXX, xxxx. X-11706;

xxxxxxxxxxxxxxxxxxxxxxxx-xxxxxxx xxxx (XXXX);

xxxxxxxxxx xxxxxxxxxxxxxxxx růstového xxxxxxx xxxx (XXX-xxxx), xxxx. sotatercept, xxxxxxxxxxxx;

1.2 Xxxxxxxx xxxxxxxxxxxxxxxxxx XXX xxxxxxxxx, např.

ARA-290;

asialo XXX;

xxxxxxxxxxxxx XXX;

2. Stabilizátory hypoxii xxxxxxxxxxxxxx faktoru (XXX), xxxx. kobalt, xxxxxxxxxx x roxadustat (FG-4592); x aktivátory XXX, xxxx. argon x xxxxx.

3. Xxxxxxxxxxxxxxxxxx (XX) x luteinizační xxxxxx (XX) x xxxxxx xxxxxxxxxx faktory, xxxx. xxxxxxxxx, xxxxxxxxxxx x xxxxxxxxxxx, x mužů.

4. Xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxx faktory, xxxx. xxxxxxxxxxxx.

5. Růstový xxxxxx (XX) a xxxx xxxxxxxxxx xxxxxxx xxxxxx: xxxxxxx uvolňujícího xxxxxxx xxxxxx (XXXX) a xxxx xxxxxxx, např. XXX-1295, xxxxxxxxxxx x xxxxxxxxxxxx; xxxxxxxxxxx xxxxxxxxx xxxxxxx (GHS), xxxx. xxxxxxxx x mimetik xxxxxxxx, xxxx. xxxxxxxxxxx x xxxxxxxxxxx; xxxxxxxxxxxx xxxxxxx růstového xxxxxxx (XXXX), např. xxxxxxxxxxxxx, XXXX-6, hexarelinu x xxxxxxxxxxxx (GHRP- 2).

Xxxxx xxxx xxxx xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxx:

Xxxxxxxxxxxxx xxxxxxx faktory (FGFs); xxxxxxxxxxxx xxxxxxx xxxxxx (XXX); insulinu xxxxxxx xxxxxxx faktor-1 (XXX-1) x jeho xxxxxxx; xxxxxxxxxx xxxxxxx xxxxxxx (XXX); xxxxxxx faktor xxxxxxxx z krevních xxxxxxxx (XXXX); xxxxxxxxxx-xxxxxxxxxxxx xxxxxxx faktor (XXXX), xxxxxx jako xxxxxxxxx xxxx xxxxxxx faktory xxxxxxxxxxx xxxxxxx xxxx xxxxxxxxx xxxxxxxx xxxxx, xxxxx x xxxxxx, xxxxxx xxxxxxxx, využití xxxxxxx, xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxx.

X3. XXXX2- XXXXXXXX

Xxxxxxx xxxxxxxxxx x xxxxxxxxxxxx beta2- xxxxxxxx, xxxxxx xxxxx xxxxxxxxx xxxxxxx, xxxx zakázáni.

Zahrnují (xxx xx s xxxxxxxx pouze xx xx):

Xxxxxxxxx; xxxxxxxxxx; higenamin; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; salmeterol; xxxxxxxxxx; xxxxxxxxxx.

Xxxxxxxx jsou:

• inhalační xxxxxxxxxx: maximálně 1600 xxxxxxxxxx za 24 xxxxx, xxxxxxxxxxx 800 xxxxxxxxxx xx xxxxxxx 12 xxxxx;
• xxxxxxxxx xxxxxxxxxx: xxxxxxxxx xxxxxx xxxxx 54 xxxxxxxxxx xx 24 xxxxx;
• xxxxxxxxx salmeterol: xxxxxxxxx 200 xxxxxxxxxx xx 24 xxxxx.

Xxxxxxxxxx xxxxxxxxxxx x xxxx x xxxxxxxxxxx xxxxx xxx 1000 xx/xx x přítomnost xxxxxxxxxxx x xxxx x xxxxxxxxxxx xxxxx než 40 xx/xx xxxxxx xxxxxxxxxx za xxxxxxxxx xxxxxxxxxxxx xxxxxxx, xxx xxxx považována xx xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx sportovec xxxxxxxxx xxxxxxxxxxxxx farmakokinetickou xxxxxx, xx xxxxxxxxxx výsledek xxx způsoben xxxxxxxx xxxxxxxxxxxx xxxxx (v xxxxxxxx) xxxxx, xxx xxxx xxxxxxx maximální xxxxx.

X4. HORMONOVÉ X XXXXXXXXXXX XXXXXXXXXX

Xxxxxxxx xxxx xxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

Xxxxxxxxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxx-1,4,6-xxxxx-3-17-xxxx (androstatriendion);

androsta-3,5-dien-7-17-dion (xxxxxxxxx);

4-xxxxxxxxx-3,6,17-xxxxx (6-oxo);

exemestan;

formestan;

letrozol;

testolacton,

ale xx x xxxxxxxx xxxxx xx ně.

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx receptorů (XXXX), zahrnující:

Raloxifen;

xxxxxxxxx;

xxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

Xxxxxxxxxx; xxxxxxxxxxx x xxxxxxxx, xxx xx x xxxxxxxx xxxxx xx ně.

4. Xxxxx modifikující xxxxxx(x) xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, ale ne

s xxxxxxxx pouze xx xx.

5. Metaboiické modulátory:

5.1 Xxxxxxxxxx AMP-aktivované proteinkinázy (XXXX), xxxx. AICAR; x Agonisté Xxxxxxxxx xxxxx xxxxxxxxxxxx peroxizomovými xxxxxxxxxxxxx (PPARδ), xxxx. XX 1516;

5.2 Insuliny x xxxxxxxx xxxxxxxx;

5.3 Xxxxxxxxx;

5.4 Xxxxxxxxxxxx.

X5. XXXXXXXXX X XXXXXXXXX XXXXX

Xxxxxxxxxxx xxxxxxxxx x maskovací xxxxx xxxx zakázané, xxxxxx xxxx xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx x xxxxxxxxx biologickými účinky.

Zahrnují:

• Desmopressin, xxxxxxxxxxxxxxx (xxxx. glycerol, xxxxxxxxxx podání xxxxxxxx, xxxxxxxx, hydroxyethylškrobu x xxxxxxxxx), probenecid, xxx xx s xxxxxxxx xxxxx xx ně.

• Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x xxxxxxx (xxxx. xxxxxxxxx), ale xx x xxxxxxxx xxxxx xx xx.

X xxxxxxxx:

• xxxxxxxxxxxx, pamabromu a xxxxxx podání inhibitorů xxxxxxxxxxxxxx (např. xxxxxxxxxxx x brinzolamidu)

• Lokálního podání xxxxxxxxxxxx xxx xxxxx xxxxxxxxx

Xxxxx xxxxxxxxxxx množství xxxxx xx xxxxxxxxxx xxxxxxxx xxxxxxx (xx. xxxxxxxxxx, salbutamol, xxxxx, xxxxxxx, xxxxxxxxxxxx x xxxxxxxxxxxxx) xx Vzorku Xxxxxxxxx xxxxxxxx xxxx

xxxxxxxx Xxx Xxxxxxx xx xxxxxxx x xxxxxxxxxx xxxx jinou xxxxxxxxx xxxxxx, bude považováno xx Pozitivní laboratorní xxxxx, pokud Sportovec xxxx xxxxxxxxxx Terapeutickou xxxxxxx (TV) xx xxxx xxxxx xxxxx x xx, která xxx xxxx xxxxxxx xx diuretikum xxxx xxxxx maskovací xxxxx.

XXXXXXXX XXXXXX

X1. XXXXXXXXXX X XXXX A KREVNÍMI XXXXXXXXXXXX

Xxxxxxxx je následující:

1. Xxxxxx xxxx znovuzavedení xxxxxxxxxxx xxxxxxxx xxxxxxxxx, xxxxxxxx (xxxxxxxxx) nebo xxxxxxxxxxx xxxx xxxx xxxxxxxxx xxxxxxx x xxx xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx xxxxxxxxx xxxxxxx.

2. Xxxxx xxxxxxxxx xxxxxxxx, xxxxxxx xxxx xxxxxxx xxxxxxx.

Xxxxxxxxxx:

xxxxxxxxxxxx xxxxxxxxxxxxx produkty (xxxx. xxxxxx xxxxxxxx založené xx xxxxxxxxxxx x xxxxxxxxxxxxxxxxxx xxxxxxxxxxx), perfluorochemikálie x xxxxxxxxxxx (XXX13), xxx ne x xxxxxxxx xxxxx na xx. Inhalační xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxx.

3. Xxxxxxxxx forma xxxxxxxxxxxxxxx xxxxxxxxxx s xxxx xxxx s xxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx.

X2. XXXXXXXX X FYZIKÁLNÍ XXXXXXXXXX

Xxxxxxxx xx následující:

1. Podvádění, xxxx Xxxxx x Xxxxxx, xx xxxxxx xxxxxxx integritu x xxxxxxxx Xxxxxx odebraných xxx Xxxxxxxxx kontrole. Xx xxxxxxxx xxxxxx x/xxxx xxxxxx (např. xxxxxxxxxx) xxxx, xxx xx x xxxxxxxx xxxxx xx xx.

2. Xxxxxxxxxx xxxxxx x/xxxx xxxxxxx xxxx než 50 xx xx 6 xxxxx xxxxx xxxxxx xxxxxxxxx xxxxxxxxx x průběhu xxxxxxxxxxxx xxxxxxx, xxxxxxxxxxxxx xxxxxxx xxxx klinických vyšetřovacích xxxxx.

X3. XXXXXX XXXXXX

X xxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxxxx výkonu xx xxxxxxxx xxxxxxxxxxx:

1. Xxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxx;

2. Xxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx;

XXXXX X XXXXXX XXXXXXXX PŘI XXXXXXX

Xxxxx xxxxxxxxx X0 xx X5 x M1 xx M3 xxxxxxxxx xxxx

xxxx Xxx Xxxxxxx xxxxxxxx x následující xxxxxxx:

XXXXXXXX LÁTKY

S6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx xxxxxx xxxxx xxxxxx případných xxxxxxxxx xxxxxxx, xxxx. x- x I-, jsou xxxxxxxx.

Xxxxxxxxxxx xxxxxxxx:

(x) Xxxxxxxxxxxx xxxxxxxxxxx:

Xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxx /4-xxxxxxxxxxxxxx (xxxxxxxx)/,

xxxxxxxxxx,

xxxxxxxxxxx,

xxxxxx,

xxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxx (x-),

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxxxx, 

x-xxxxxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx.

Xxxxxxxxxxxx, které xxxx xxxxxxxx uvedeno x xxxxx xxxxxxxx, xx Xxxxxxxxxxx xxxxxx.

(x) Xxxxxxxxxx xxxxxxxxxxx.

Xxxxxxxx (xxx ne x xxxxxxxx pouze xx xx):

Xxxxxxxxx (epinefrin)****,

benzfetamin,

dimethylamfetamin,

efedrin***,

etamivan,

etylamfetamin,

etylefrin,

famprofazon,

fenbutrazát,

fenetylamin x jeho xxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxx),

xxxxxxxxxxxx,

xxxxx**,

xxxxxxx x xxxx xxxxxxx (xxxx. xxxxxxxx, xxxxxxxxx a xxxx-xxxxxxxxxxxxxxxxxxxxx),

xxxxxxxxxxxxxxx,

xxxxxxxxxxxx,

xxxxxxxxxxxx***,

xxxxxxxxxxxxxxxxxxxxxxxx,

xxxxxxxxxxxx,

4-xxxxxxxxxx-2-xxxx (xxxxxxxxxxxxxx),

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxx (xxxxxxxxxxxxx),

xxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxxxx,

xxxxxxxxxxxxx*****,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxx (metylendioxyamfetamin),

tuaminoheptan

a xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

X xxxxxxxx:

• xxxxxxxxx

• xxxxxxxx xxxxxxxxx x xxxxxxx xxxxxx xxxxxxxx/xxxxxx xxxxxxx x xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2017*.

* Bupropion, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxx, xxxxxxx, xxxxxxxxx a xxxxxxxx: Tyto látky xxxx zahrnuté xx Xxxxxxxxxxxxxx programu 2017 x xxxxxx xxxxxxxxxx xx Xxxxxxxx xxxxx.

** Xxxxx: xx xxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 5 xxxxxxxxxx x 1 xx moči.

*** Efedrin x xxxxxxxxxxxxx: jsou xxxxxxxx xxx xxxxxxxxxxx xxxxx xxx 10 xxxxxxxxxx x 1 xx xxxx.

**** Adrenalin (xxxxxxxxx): xxxx xxxxxxx xxx xxxxxxxx xxxxxx, xxxx. xxxxx, xxxx xxxxxxxx xxxx xxxx xxxxxx společně s xxxxxxxxx xxxxxxxxxx.

***** Xxxxxxxxxxxxx: xx xxxxxxx, xxxxx xxxx koncentrace x xxxx je xxxxx xxx 150 xxxxxxxxxx xx xxxxxxxx.

X7. XXXXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

Xxxxxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxx(xxxxxx),

xxxxxxxx x xxxx xxxxxxxx,

xxxxxxxxxxx,

xxxxxxx,

xxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxx.

X8. KANABINOIDY

Zakázané xx xxxxxxxxxxx:

• Xxxxxxxx (např. xxxxx, konopí a xxxxxxxxx) xxxx xxxxxxxxxx xxxxx9-xxxxxxxxxxxxxxxxxxx (XXX).

• Xxxxxxxxxxxxxx, např. "Xxxxx", XXX018, XXX073 x XX-210.

X9. XXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx jsou xxxxxxxx.

XXXXX ZAKÁZANÉ X&xxxx;XXXXXXXX XXXXXXXX

X1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx pouze Xxx Xxxxxxx v xxxxxxxxxxxxx sportech. Xxxxxxx xx bude provádět xxxxxxxx zkouškou a/nebo xxxxxxxx xxxx. Xxxxxxx xxxxxxx pro xxxxxxxx xxxxxxxxxxx pravidla je xxxxxxxxxxxx koncentraci alkoholu x xxxx 0,10 x/x.

• Xxxxxxxxxxxx xxxxx (FIA)

• Lukostřelba (XX)

• Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)

• Xxxxx motorismus (XXX)

X2. XXXX-XXXXXXXXX

Xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx x xxxxxxxxxxxxx xxxxxxxx Při Xxxxxxx, a xxx xx to xxxxxxxx x Mimo xxxxxx.

• Xxxxxxxxxxxx xxxxx (XXX)

• Xxxxxxxx (xxxxxxx xxxxxxxxxx) (XXXX)

• Xxxx (XXX)

• Xxxxxxxxxxx (XX)*

• Xxxxxxxx (XXX) - xxxxx xx xxxxxx x xxxxxxxxxxx lyžování-skoky x X-xxxxx, a xxxxxxxxx U-rampa a "xxx xxx"

• Xxxxxxxx sporty (xxxxxxxxx potápění) (XXXX) x disciplínách xxxxxxxxxx xxxx s xxxxxxxxx xxxx bez ploutví, xxxxxxxxx apnoe x xxxxxxxxx nebo xxx xxxxxxx, free immersion, xxxx blue, spearfishing, xxxxxxxx xxxxx, xxxxxxx xxxxxxxx xx xxxx x xxxxxxxxxx váha.

• Střelba (XXXX, XXX)*

• Xxxxx (WDF)

* Xxxxxxxx také Mimo xxxxxx

Xxxx-xxxxxxxxx zahrnují následující xxxxx:

Xxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxx,

xxxxxxxxxx,

xxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxx,

xxxxxxxxxx, 

xxxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxxxx,

xxxxxxx,

xxxxxxx,

xxx xx x xxxxxxxx pouze xx xx.

Xxxxxxxxx

Xxxxxx xxxxxxx č. 80/2017 Xx. m. x. xxxxx xxxxxxxxx xxxx 4.1.2018.

Právní xxxxxxx x. 80/2017 Xx. x. x. xxx xxxxxx xxxxxxx předpisem č. 36/2019 Sb. m. s. x xxxxxxxxx xx 26.7.2019.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.

1) Mezinárodní xxxxxx xxxxx xxxxxxx xx xxxxxx, přijatá xxx 19. xxxxx 2005 x Paříži, byla xxxxxxxxx x anglickém xxxxx a s xxxxxxxxx xx xxxxxxx xxxxxx xxx č. 58/2007 Sb. m. s.

Xxxx xxxxx xxxxxxxx Xxxxxx xx xxxxxxx xxxxxx xxxx xxxxxxxxx xxx č. 46/2008 Sb. m. s.